ICU Medical, Inc. Announces Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq poised to lead Wall St after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Roth Capital Raises Price on ICU Medical (ICUI) to $124 Following 2Q EPS Beat and Raise
August 11, 2015 8:17 AM EDTRoth Capital reiterated a Buy rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $124.00 (from $102.00), following the company's 2Q earnings release. 2Q revenues of $83.8 million beat Street's $78.89 million estimate. Adjusted EPS of $0.97 beat Street's $0.69. ICUI raised its annual outlook, which... More
ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
August 10, 2015 5:22 PM EDTICU Medical (NASDAQ: ICUI) reported Q2 EPS of $0.97, $0.28 better than the analyst estimate of $0.69. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $78.89 million.
ICU Medical sees FY2015 EPS of $2.63-$2.83, versus prior guidance of $2.15-$2.25. ICU Medical sees... More
